Atsuhiro Sugidachi

2.7k total citations
64 papers, 2.2k citations indexed

About

Atsuhiro Sugidachi is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, Atsuhiro Sugidachi has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 28 papers in Hematology and 17 papers in Internal Medicine. Recurrent topics in Atsuhiro Sugidachi's work include Antiplatelet Therapy and Cardiovascular Diseases (44 papers), Platelet Disorders and Treatments (20 papers) and Venous Thromboembolism Diagnosis and Management (17 papers). Atsuhiro Sugidachi is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (44 papers), Platelet Disorders and Treatments (20 papers) and Venous Thromboembolism Diagnosis and Management (17 papers). Atsuhiro Sugidachi collaborates with scholars based in Japan, United States and Germany. Atsuhiro Sugidachi's co-authors include Joseph A. Jakubowski, Fumitoshi Asai, Taketoshi Ogawa, Y. Niitsu, Kenneth J. Winters, Christoph Varenhorst, David Erlinge, Stefan James, Oscar Ö. Braun and Hiroyuki Koike and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Atsuhiro Sugidachi

64 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Atsuhiro Sugidachi Japan	19	1.7k	784	515	354	291	64	2.2k
J.J.J. van Giezen Sweden	20	1.3k 0.7×	441 0.6×	542 1.1×	369 1.0×	126 0.4×	41	1.9k
Jean‐Marie Pereillo France	9	846 0.5×	294 0.4×	184 0.4×	166 0.5×	263 0.9×	12	1.3k
C. Picard France	11	728 0.4×	264 0.3×	156 0.3×	112 0.3×	289 1.0×	20	1.3k
Jean Combalbert France	12	778 0.4×	309 0.4×	169 0.3×	120 0.3×	282 1.0×	14	1.8k
Taketoshi Ogawa Japan	14	541 0.3×	240 0.3×	147 0.3×	166 0.5×	118 0.4×	30	827
Madhu Chintala United States	17	614 0.4×	153 0.2×	182 0.4×	524 1.5×	96 0.3×	50	1.4k
P.D. Winocour Canada	20	493 0.3×	238 0.3×	107 0.2×	270 0.8×	195 0.7×	57	1.4k
Jean‐Louis David Belgium	19	481 0.3×	282 0.4×	172 0.3×	189 0.5×	149 0.5×	41	1.0k
Martin Armstrong United Kingdom	19	968 0.6×	391 0.5×	216 0.4×	69 0.2×	250 0.9×	31	1.9k
Christer Mattsson Sweden	24	570 0.3×	259 0.3×	463 0.9×	671 1.9×	34 0.1×	49	1.5k

Countries citing papers authored by Atsuhiro Sugidachi

Since Specialization

Citations

This map shows the geographic impact of Atsuhiro Sugidachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuhiro Sugidachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuhiro Sugidachi more than expected).

Fields of papers citing papers by Atsuhiro Sugidachi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuhiro Sugidachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuhiro Sugidachi. The network helps show where Atsuhiro Sugidachi may publish in the future.

Co-authorship network of co-authors of Atsuhiro Sugidachi

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuhiro Sugidachi. A scholar is included among the top collaborators of Atsuhiro Sugidachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuhiro Sugidachi. Atsuhiro Sugidachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mizuno, Makoto, et al.. (2016). A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats. PLoS ONE. 11(4). e0154661–e0154661. 6 indexed citations

Ohno, Kousaku, et al.. (2014). Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel. Thrombosis Research. 134(4). 889–894. 8 indexed citations

Angiolillo, Dominick J., Joseph A. Jakubowski, José Luis Ferreiro, et al.. (2014). Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease. Journal of the American College of Cardiology. 64(10). 1005–1014. 134 indexed citations

Berny‐Lang, Michelle A., Joseph A. Jakubowski, Atsuhiro Sugidachi, et al.. (2013). P2Y ₁₂ Receptor Blockade Augments Glycoprotein IIb‐IIIa Antagonist Inhibition of Platelet Activation, Aggregation, and Procoagulant Activity. Journal of the American Heart Association. 2(3). e000026–e000026. 16 indexed citations

Sugidachi, Atsuhiro, Shinji Yamaguchi, Paul Barragan, et al.. (2011). Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y12 inhibition. Thrombosis and Haemostasis. 107(2). 388–395. 16 indexed citations

Jakubowski, Joseph A., et al.. (2011). Evaluation of the INNOVANCE PFA P2Y test cartridge: Sensitivity to P2Y₁₂blockade and influence of anticoagulant. Platelets. 23(2). 106–115. 28 indexed citations

Rauch, Bernhard H., A Rosenkranz, Andreas Böhm, et al.. (2010). Regulation of Functionally Active P2Y12 ADP Receptors by Thrombin in Human Smooth Muscle Cells and the Presence of P2Y12 in Carotid Artery Lesions. Arteriosclerosis Thrombosis and Vascular Biology. 30(12). 2434–2442. 49 indexed citations

Ogawa, Taketoshi, Masami Hashimoto, Y. Niitsu, et al.. (2009). Effects of prasugrel, a novel P2Y12 inhibitor, in rat models of cerebral and peripheral artery occlusive diseases. European Journal of Pharmacology. 612(1-3). 29–34. 13 indexed citations

Erlinge, David, Christoph Varenhorst, Oscar Ö. Braun, et al.. (2008). Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo. Journal of the American College of Cardiology. 52(24). 1968–1977. 172 indexed citations

10.

Frelinger, Andrew L., J.A. Jakubowski, M.R. BARNARD, et al.. (2007). The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. Journal of Thrombosis and Haemostasis. 98(1). 192–200. 5 indexed citations

11.

Hashimoto, Masami, Atsuhiro Sugidachi, Takashi Isobe, et al.. (2007). The influence of P2Y12 receptor deficiency on the platelet inhibitory activities of prasugrel in a mouse model: Evidence for specific inhibition of P2Y12 receptors by prasugrel. Biochemical Pharmacology. 74(7). 1003–1009. 26 indexed citations

12.

Jakubowski, Joseph A., Marc R. Barnard, Marsha L. Fox, et al.. (2007). The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. Thrombosis and Haemostasis. 98(7). 192–200. 38 indexed citations

13.

Tanaka, Naoki, Toyoki Nishimata, Atsuhiro Sugidachi, et al.. (2006). Indoline Derivatives I: Synthesis and Factor Xa (FXa) Inhibitory Activities. Chemical and Pharmaceutical Bulletin. 54(2). 163–174. 17 indexed citations

14.

Niitsu, Y., Joseph A. Jakubowski, Atsuhiro Sugidachi, & Fumitoshi Asai. (2005). Pharmacology of CS-747 (prasugrel, LY640315), a Novel, Potent Antiplatelet Agent with in Vivo P2Y₁₂Receptor Antagonist Activity. Seminars in Thrombosis and Hemostasis. 31(2). 184–194. 192 indexed citations

15.

Ogawa, Taketoshi, Atsuhiro Sugidachi, Naoki Tanaka, Koichi Fujimoto, & Fumitoshi Asai. (2004). Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease. Vascular Pharmacology. 41(1). 7–13. 7 indexed citations

16.

Tanaka, Naoki, Ryota Goto, Rie Ito, et al.. (2000). [2-(.OMEGA.-Phenylalkyl)phenoxy]alkylamines. III. Synthesis and Selective Serotonin-2 Receptor Binding. (2).. Chemical and Pharmaceutical Bulletin. 48(11). 1729–1739. 9 indexed citations

17.

Asai, Fumitoshi, Shinya Saito, Hiroshi Ozaki, et al.. (1998). Inhibition of Rat Platelet Aggregation by Mycalolide-B, a Novel Inhibitor of Actin Polymerization with a Different Mechanism of Action from Cytochalasin-D. Thrombosis and Haemostasis. 79(3). 614–619. 9 indexed citations

18.

Sugidachi, Atsuhiro, Fumitoshi Asai, Takeshi Oshima, & Hiroyuki Koike. (1993). Age-associated Changes in Intracellular Ca²⁺Mobilization and Basal pH Level in Rat Platelets. Platelets. 4(2). 91–95. 1 indexed citations

19.

Sugidachi, Atsuhiro, Fumitoshi Asai, & Hiroyuki Koike. (1993). In vivo pharmacology of aprosulate, a new synthetic polyanion with anticoagulant activity. Thrombosis Research. 69(1). 71–80. 8 indexed citations

20.

Watanabe, Masako, et al.. (1987). Platelet-Activating Factor in the Inflammatory Exudate in the Anaphylactic Phase of Allergic Inflammation in Rats. International Archives of Allergy and Immunology. 84(4). 396–403. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact